Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

By: News Direct

March 09, 2023 at 07:53 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

Is Backblaze the Next Momentum Monster? ↗

Today 14:10 EDT

Via MarketBeat

The AI Fear Around Datadog Stock May Have Been Completely Wrong ↗

Today 13:35 EDT

Via MarketBeat

IonQ Just Posted a Breakout Quarter—But 1 Problem Remains ↗

Today 13:00 EDT

Via MarketBeat

3 REITs to Watch as AI Data Center Spending Surpasses Office Construction ↗

Today 13:00 EDT

Via MarketBeat

Uber's Annual Product Showcase Reveals It Is Coming for Airbnb and Booking ↗

Today 12:25 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	271.17	-3.82 (-1.39%)
AAPL	287.44	-0.07 (-0.02%)
AMD	408.46	-12.93 (-3.07%)
BAC	52.75	-0.85 (-1.59%)
GOOG	395.30	+0.16 (0.04%)
META	616.81	+3.93 (0.64%)
MSFT	420.77	+6.81 (1.65%)
NVDA	211.50	+3.67 (1.77%)
ORCL	194.59	+0.56 (0.29%)
TSLA	411.79	+13.06 (3.28%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.